Health Trials

Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Hypoxic Red Blood Cells in Sickle Cell Anemia

The overall objective of this study is to evaluate the effectiveness and safety of transfusing hypoxic red blood cells manufactured with the Hemanext ONE system in patients with sickle cell anemia. The Hemanext ONE device was cleared through the De Novo process in September 2023.

Participants needed: 48
Trial details
Age: 7+Biological sex: AllType: InterventionalSponsor: HemanextUpdated: Jan 7, 2026Locations: 6
Eligibility criteria

Male or female at least 7 years of age; [+4]

Are not exclusively transfused at the site; [+9]

Read more
Status: Recruiting

Comparison of Hemanext ONE® System and Conventional Red Blood Cell Transfusion

The overall objective of this study is to collect preliminary effectiveness and safety data on the transfusion of hypoxic RBCs, manufactured with the Hemanext ONE device, in patients with hematological malignancies. The Hemanext ONE device received CE mark in April 2021.

Participants needed: 24
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: HemanextUpdated: Jan 7, 2026Locations: 1
Eligibility criteria

Male or female aged 18 or older [+8]

Have a life expectancy of less than 1 year [+12]

Read more